233 related articles for article (PubMed ID: 27096694)
1. Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies.
Mansourian M; Haghjooy-Javanmard S; Eshraghi A; Vaseghi G; Hayatshahi A; Thomas J
J Pharm Pharm Sci; 2016; 19(1):72-81. PubMed ID: 27096694
[TBL] [Abstract][Full Text] [Related]
2. Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis.
Jaiswal V; Agrawal V; Ang SP; Saleeb M; Ishak A; Hameed M; Rajak K; Kalra K; Jaiswal A
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):731-740. PubMed ID: 37562940
[TBL] [Abstract][Full Text] [Related]
3. Effect of statins use on risk and prognosis of breast cancer: a meta-analysis.
Zhao G; Ji Y; Ye Q; Ye X; Wo G; Chen X; Shao X; Tang J
Anticancer Drugs; 2022 Jan; 33(1):e507-e518. PubMed ID: 34407042
[TBL] [Abstract][Full Text] [Related]
4. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
Liu B; Yi Z; Guan X; Zeng YX; Ma F
Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
[TBL] [Abstract][Full Text] [Related]
5. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.
Manthravadi S; Shrestha A; Madhusudhana S
Int J Cancer; 2016 Sep; 139(6):1281-8. PubMed ID: 27176735
[TBL] [Abstract][Full Text] [Related]
6. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Xia DK; Hu ZG; Tian YF; Zeng FJ
Drug Des Devel Ther; 2019; 13():405-422. PubMed ID: 30774306
[TBL] [Abstract][Full Text] [Related]
7. Statin use and risk of breast cancer: a meta-analysis of observational studies.
Undela K; Srikanth V; Bansal D
Breast Cancer Res Treat; 2012 Aug; 135(1):261-9. PubMed ID: 22806241
[TBL] [Abstract][Full Text] [Related]
8. Statin drugs to reduce breast cancer recurrence and mortality.
Beckwitt CH; Brufsky A; Oltvai ZN; Wells A
Breast Cancer Res; 2018 Nov; 20(1):144. PubMed ID: 30458856
[TBL] [Abstract][Full Text] [Related]
9. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
[TBL] [Abstract][Full Text] [Related]
10. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors.
Kwan ML; Habel LA; Flick ED; Quesenberry CP; Caan B
Breast Cancer Res Treat; 2008 Jun; 109(3):573-9. PubMed ID: 17674197
[TBL] [Abstract][Full Text] [Related]
11. Statins: a role in breast cancer therapy?
Borgquist S; Bjarnadottir O; Kimbung S; Ahern TP
J Intern Med; 2018 Oct; 284(4):346-357. PubMed ID: 29923256
[TBL] [Abstract][Full Text] [Related]
12. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
[TBL] [Abstract][Full Text] [Related]
13. Statin use and breast cancer survival: a nationwide cohort study from Finland.
Murtola TJ; Visvanathan K; Artama M; Vainio H; Pukkala E
PLoS One; 2014; 9(10):e110231. PubMed ID: 25329299
[TBL] [Abstract][Full Text] [Related]
14. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.
Chae YK; Valsecchi ME; Kim J; Bianchi AL; Khemasuwan D; Desai A; Tester W
Cancer Invest; 2011 Nov; 29(9):585-93. PubMed ID: 21936625
[TBL] [Abstract][Full Text] [Related]
15. The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis.
Tan P; Wei S; Yang L; Tang Z; Cao D; Liu L; Lei J; Fan Y; Gao L; Wei Q
Sci Rep; 2016 Jul; 6():29106. PubMed ID: 27384548
[TBL] [Abstract][Full Text] [Related]
16. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies.
Wan YD; Sun TW; Kan QC; Guan FX; Zhang SG
Crit Care; 2014 Apr; 18(2):R71. PubMed ID: 24725598
[TBL] [Abstract][Full Text] [Related]
17. Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.
Nickels S; Vrieling A; Seibold P; Heinz J; Obi N; Flesch-Janys D; Chang-Claude J
PLoS One; 2013; 8(9):e75088. PubMed ID: 24086446
[TBL] [Abstract][Full Text] [Related]
18. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
Lahart IM; Metsios GS; Nevill AM; Carmichael AR
Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
[TBL] [Abstract][Full Text] [Related]
19. Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.
Mei Z; Liang M; Li L; Zhang Y; Wang Q; Yang W
Int J Cancer; 2017 Mar; 140(5):1068-1081. PubMed ID: 27859151
[TBL] [Abstract][Full Text] [Related]
20. β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis.
Childers WK; Hollenbeak CS; Cheriyath P
Clin Breast Cancer; 2015 Dec; 15(6):426-31. PubMed ID: 26516037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
